NeutriSci International Inc

Healthcare CA NU

NoneCAD
0.00(0%)

Last update at 2026-06-22T21:08:04.597871Z

Day Range

LowHigh

52 Week Range

11.4618.98

LowHigh

Fundamentals

Previous Close 12.71
Market Cap0.89M
VolumeNone
P/E Ratio-
Dividend Yield-%
EBITDA-0.53261M
Revenue TTM0.06M
Revenue Per Share TTM-
Gross Profit TTM -0.10295M
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Income before tax	-0.55245M	-0.77069M	-1.57220M	-1.95255M	-1.61287M
Minority interest	-	-	-	-	-
Net income	-0.55245M	-0.77069M	-1.57220M	-1.95255M	-1.61287M
Selling general administrative	0.44M	0.60M	1.25M	1.71M	1.42M
Selling and marketing expenses	-	0.00396M	0.07M	0.21M	0.23M
Gross profit	-0.02632M	-0.04341M	-0.02055M	-0.00587M	0.00294M
Reconciled depreciation	0.03M	0.04M	0.05M	0.03M	0.00504M
Ebit	-	-0.69031M	-1.36370M	-1.94427M	-1.65145M
Ebitda	-	-0.65305M	-1.31859M	-1.91697M	-1.64641M
Depreciation and amortization	-	0.04M	0.05M	0.03M	0.00504M
Non operating income net other	-	-	-	-	-
Operating income	-0.50465M	-0.69031M	-1.36370M	-1.94427M	-1.65145M
Other operating expenses	-	1.15M	1.47M	2.02M	1.75M
Interest expense	0.00223M	0.00097M	0.00100M	0.00138M	0.00118M
Tax provision	-	-	-	-	-
Interest income	-	-	-	-	-
Net interest income	-0.00223M	-0.00097M	-0.00100M	-0.00138M	-0.00118M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	0.03M	0.00138M	0.00118M
Total revenue	0.06M	0.46M	0.08M	0.07M	0.10M
Total operating expenses	0.56M	0.65M	1.37M	1.94M	1.65M
Cost of revenue	0.09M	0.50M	0.10M	0.08M	0.09M
Total other income expense net	-0.04557M	-0.08038M	-0.18298M	-0.00689M	0.04M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-0.55245M	-0.77069M	-1.57220M	-1.95255M	-1.61287M
Net income applicable to common shares	-	-0.77069M	-0.77069M	-1.95255M	-1.61287M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Total assets	0.33M	0.82M	0.53M	0.50M	0.55M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	-	-	-	-	-
Total liab	0.95M	0.87M	0.62M	0.66M	0.28M
Total stockholder equity	-0.61697M	-0.04760M	-0.09024M	-0.15624M	0.28M
Deferred long term liab	-	-	-	-	-
Other current liab	0.04M	0.27M	0.07M	0.07M	0.03M
Common stock	31.03M	-	29.62M	28.14M	27.30M
Capital stock	31.03M	30.89M	29.62M	28.14M	27.30M
Retained earnings	-36.47086M	-35.70016M	-34.12797M	-32.17542M	-30.56255M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	-	-	-	-	-
Cash	0.18M	0.03M	0.00737M	0.00010M	0.28M
Cash and equivalents	-	-	-	-	-
Total current liabilities	0.89M	0.81M	0.62M	0.66M	0.28M
Current deferred revenue	-	-	-	-	-
Net debt	0.00336M	0.03M	-	0.05M	-
Short term debt	-	-	-	-	-
Short long term debt	0.12M	-	-	0.05M	-
Short long term debt total	-	-	-	-	-
Other stockholder equity	0.30M	-	0.45M	0.32M	0.27M
Property plant equipment	0.13M	-	0.21M	0.02M	0.02M
Total current assets	0.20M	0.65M	0.31M	0.49M	0.53M
Long term investments	-	-	-	-	-
Net tangible assets	-0.61697M	-	-0.09024M	-0.15624M	0.28M
Short term investments	-	-	-	-	-
Net receivables	0.00881M	-	0.01M	0.02M	0.08M
Long term debt	0.06M	0.06M	-	-	-
Inventory	0.01M	0.49M	0.27M	0.34M	0.12M
Accounts payable	0.73M	0.44M	0.52M	0.48M	0.24M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-	-	-	-	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	0.02M	0.02M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.13M	0.17M	0.21M	0.02M	0.02M
Capital lease obligations	-	-	-	-	-
Long term debt total	-	-	-	-	-

Breakdown	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Investments	0.00000M	-0.00475M	-0.10743M	-0.11048M	-0.01315M
Change to liabilities	-	-0.02881M	0.00000M	-0.10519M	0.35M
Total cashflows from investing activities	-	-0.00475M	-0.00475M	-0.11048M	-0.11048M
Net borrowings	-	0.12M	0.12M	-0.04716M	0.04M
Total cash from financing activities	0.26M	0.32M	1.17M	1.64M	0.97M
Change to operating activities	-	0.11M	0.11M	0.10M	-0.05872M
Net income	-0.55245M	-0.77069M	-1.57220M	-1.95255M	-1.61287M
Change in cash	-0.00607M	0.14M	0.02M	0.00727M	-0.27495M
Begin period cash flow	0.00840M	0.03M	0.00737M	0.00010M	0.28M
End period cash flow	0.00233M	0.18M	0.03M	0.00737M	0.00010M
Total cash from operating activities	-0.26469M	-0.16609M	-1.04082M	-1.52122M	-1.24092M
Issuance of capital stock	-	0.20M	0.40M	1.55M	0.93M
Depreciation	0.03M	0.04M	0.05M	0.03M	0.00504M
Other cashflows from investing activities	-	-	-	-	-
Dividends paid	-	-	-	-	-
Change to inventory	0.04M	0.42M	-0.33634M	0.07M	-0.22724M
Change to account receivables	-0.00163M	-0.00146M	0.00052M	0.00504M	0.00153M
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	-	0.24M	0.85M	0.13M	0.08M
Change to netincome	-	0.06M	0.06M	0.33M	0.30M
Capital expenditures	0.00000M	0.00475M	0.11M	0.11M	0.11M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.21M	0.50M	-0.10695M	0.07M	0.07M
Stock based compensation	0.00000M	0.00455M	0.50M	0.33M	0.26M
Other non cash items	-	0.06M	0.09M	0.00138M	0.00118M
Free cash flow	-0.26469M	-0.17084M	-1.14825M	-1.63170M	-1.24092M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (CAD)	Price (CAD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
NU NeutriSci International Inc	- -%	-	-	-	29.75	20.29	33.24	-3.8505
RX Biosyent Inc.	0.05 0.36%	14.00	19.10	15.85	3.96	4.11	3.31	11.03
DB Decibel Cannabis Company Inc	- -%	0.12	-	8.67	0.67	1.20	0.99	17.75
ZYUS ZYUS Life Sciences Corporation	- -%	0.50	-	-	108.48	4.41	140.29	-4.258
LSL LSL Pharma Group Inc.	0.005 1.59%	0.32	20.75	-	1.88	1.89	2.85	10.19

Reports Covered

View All

Profile

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

NeutriSci International Inc

1600 ? 609 Granville Street, Vancouver, BC, Canada, V7Y 1C3

403 264 6320
https://www.neutrisci.com

Key Executives

Name	Title	Year Born
Mr. William C. Adams IV	VP and Trustee	1956
Mr. Thomas C. Spalding Jr., CFA	Portfolio Mang.	1962
Mr. Daniel S. Solender	Portfolio Mang.	1967
Mr. Johnathan N. Wilhelm J.D.	Portfolio Mang.	NA
Mr. Glen Rehman	CEO, President & Director	NA
Mr. John Robert Chisholm	Chief Financial Officer	1962
Ms. Jaycee Waters	Operations & Logistics Manager	NA
Mr. Thierry Sorhaitz	Vice President of Sales & Marketing	NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.